[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
June 1990

The Surgeon and Colorectal Cancer GeneticsCase Identification, Surveillance, and Management Strategies

Author Affiliations

Omaha, Neb

Arch Surg. 1990;125(6):698-701. doi:10.1001/archsurg.1990.01410180016002

Research in the causes of colorectal cancer (CRC) has accelerated at an explosive rate during the past two decades.1 Much has changed since Sklifasowski2 first noted the connection between polyps and CRC. Its genetic implications subsequently led to the characterization of familial adenomatous polyposis (FAP), which is unquestionably the best known example of hereditary (autosomal-dominant) CRC.

Familial adenomatous polyposis has been a great teacher. It had been considered for many decades to be a very simplistic disease, with its phenotype (colonic polyps and cancer) restricted to the colon. However, in the early 1950s, Gardner and Richards3 significantly changed this concept when they described extracolonic signs, namely, cutaneous (epidermoid cysts) and osseous (osteomas), in a large kindred prone to colonic polyps and CRC. This variant is now known as Gardner's syndrome. Nakamura et al4 subsequently showed that Gardner's syndrome was linked to the FAP locus on the

First Page Preview View Large
First page PDF preview
First page PDF preview